Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Increased expression of cytokines, soluble cytokine receptors, soluble apoptosis ligand and apoptosis in dengue" [Virology 452-453 (2014) 42-51].

Virology·2015
Same author

[Allergic rhinitis in asthmatic patients].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2014
Same author

Increased expression of cytokines, soluble cytokine receptors, soluble apoptosis ligand and apoptosis in dengue.

Virology·2014
Same author

[Science, reason for the existence of the University].

Investigacion clinica·2011
Same author

[Viral etiology of acute respiratory infections].

Investigacion clinica·2009
Same author

[Presence of urban rabies in Zulia State, Venezuela. Years 1996-2006].

Investigacion clinica·2009

Related Experiment Video

Updated: Jun 29, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

[Indication for haemoderivatives in dengue].

Yraima Larreal

    Investigacion Clinica
    |October 14, 2008
    PubMed
    Summary

    Careful management of dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) focuses on fluid replacement. Preventive blood transfusions are not beneficial and may increase hospitalization and risks.

    Area of Science:

    • Critical care medicine
    • Infectious diseases
    • Hematology

    Background:

    • Dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) management necessitates specialized care.
    • Treatment relies on physiological replacement therapy and meticulous fluid control.

    Discussion:

    • Blood product transfusion criteria are specific, particularly during disseminated intravascular coagulation (DIC) in the hemorrhagic phase.
    • Close monitoring of bleeding manifestations and laboratory parameters is essential.

    Key Insights:

    • Preventive transfusion offers no advantages in treating DHF/DSS.
    • Prophylactic transfusions are associated with increased hospitalization duration and pulmonary edema development.

    Outlook:

    More Related Videos

    Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen
    06:00

    Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen

    Published on: January 26, 2024

    Protocol for Dengue Infections in Mosquitoes (A. aegypti) and Infection Phenotype Determination
    15:25

    Protocol for Dengue Infections in Mosquitoes (A. aegypti) and Infection Phenotype Determination

    Published on: July 4, 2007

    Related Experiment Videos

    Last Updated: Jun 29, 2026

    A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
    04:23

    A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

    Published on: April 28, 2019

    Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen
    06:00

    Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen

    Published on: January 26, 2024

    Protocol for Dengue Infections in Mosquitoes (A. aegypti) and Infection Phenotype Determination
    15:25

    Protocol for Dengue Infections in Mosquitoes (A. aegypti) and Infection Phenotype Determination

    Published on: July 4, 2007

    • Further research into optimal transfusion triggers during DHF/DSS is warranted.
    • Focus on evidence-based fluid management and risk mitigation strategies for transfusion-related complications.